The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans
Ronald J. Ozminkowski, William D. Marder, Kevin Hawkins, Shaohung Wang, Sarah C. Stallings, Stan N. Finkelstein, Anthony J. Sinskey, David WierzVolume:
26
Year:
2004
Language:
english
DOI:
10.1016/s0149-2918(04)80225-x
File:
PDF, 1.22 MB
english, 2004